Literature DB >> 9113977

A general purpose RNA-cleaving DNA enzyme.

S W Santoro1, G F Joyce.   

Abstract

An in vitro selection procedure was used to develop a DNA enzyme that can be made to cleave almost any targeted RNA substrate under simulated physiological conditions. The enzyme is comprised of a catalytic domain of 15 deoxynucleotides, flanked by two substrate-recognition domains of seven to eight deoxynucleotides each. The RNA substrate is bound through Watson-Crick base pairing and is cleaved at a particular phosphodiester located between an unpaired purine and a paired pyrimidine residue. Despite its small size, the DNA enzyme has a catalytic efficiency (kcat/Km) of approximately 10(9) M-1.min-1 under multiple turnover conditions, exceeding that of any other known nucleic acid enzyme. Its activity is dependent on the presence of Mg2+ ion. By changing the sequence of the substrate-recognition domains, the DNA enzyme can be made to target different RNA substrates. In this study, for example, it was directed to cleave synthetic RNAs corresponding to the start codon region of HIV-1 gag/pol, env, vpr, tat, and nef mRNAs.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1997        PMID: 9113977      PMCID: PMC20710          DOI: 10.1073/pnas.94.9.4262

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

2.  Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity.

Authors:  P Dash; I Lotan; M Knapp; E R Kandel; P Goelet
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  RNA catalytic properties of the minimum (-)sTRSV sequence.

Authors:  A Hampel; R Tritz
Journal:  Biochemistry       Date:  1989-06-13       Impact factor: 3.162

4.  The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme.

Authors:  C Guerrier-Takada; K Gardiner; T Marsh; N Pace; S Altman
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

5.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

Authors:  P C Zamecnik; M L Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

6.  A DNA enzyme with Mg(2+)-dependent RNA phosphoesterase activity.

Authors:  R R Breaker; G F Joyce
Journal:  Chem Biol       Date:  1995-10

7.  Co-operative non-enzymic base recognition. 3. Kinetics of the helix-coil transition of the oligoribouridylic--oligoriboadenylic acid system and of oligoriboadenylic acid alone at acidic pH.

Authors:  D Pörschke; M Eigen
Journal:  J Mol Biol       Date:  1971-12-14       Impact factor: 5.469

8.  Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena.

Authors:  K Kruger; P J Grabowski; A J Zaug; J Sands; D E Gottschling; T R Cech
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

9.  Comparison of the kinetics of ribooligonucleotide, deoxyribooligonucleotide, and hybrid oligonucleotide double-strand formation by temperature-jump kinetics.

Authors:  J W Nelson; I Tinoco
Journal:  Biochemistry       Date:  1982-10-12       Impact factor: 3.162

10.  Human hepatitis delta virus RNA subfragments contain an autocleavage activity.

Authors:  H N Wu; Y J Lin; F P Lin; S Makino; M F Chang; M M Lai
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

View more
  337 in total

Review 1.  Gene therapy of hepatic diseases: prospects for the new millennium.

Authors:  K Shetty; G Y Wu; C H Wu
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  Structural diversity of self-cleaving ribozymes.

Authors:  J Tang; R R Breaker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Inhibition of hepatitis B virus X gene expression by novel DNA enzymes.

Authors:  R Goila; A C Banerjea
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

Review 4.  Chemical approaches to control gene expression.

Authors:  J M Gottesfeld; J M Turner; P B Dervan
Journal:  Gene Expr       Date:  2000

Review 5.  Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function.

Authors:  L M Khachigian
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

6.  In vitro-selected RNA cleaving DNA enzymes from a combinatorial library are potent inhibitors of HIV-1 gene expression.

Authors:  B Sriram; A C Banerjea
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

7.  Homogeneous assays based on deoxyribozyme catalysis.

Authors:  M N Stojanovic; P de Prada; D W Landry
Journal:  Nucleic Acids Res       Date:  2000-08-01       Impact factor: 16.971

8.  A general approach for the use of oligonucleotide effectors to regulate the catalysis of RNA-cleaving ribozymes and DNAzymes.

Authors:  Dennis Y Wang; Beatrice H Y Lai; Anat R Feldman; Dipankar Sen
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

Review 9.  Nonviral gene transfer strategies for the vasculature.

Authors:  Jennifer L Young; David A Dean
Journal:  Microcirculation       Date:  2002-01       Impact factor: 2.628

Review 10.  Pulling strings below the surface: hormone receptor signaling through inhibition of protein tyrosine phosphatases.

Authors:  X Espanel; S Wälchli; R P Gobert; M El Alama; M L Curchod; N Gullu-Isler; R Hooft van Huijsduijnen
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.